表紙:デュシェンヌ型筋ジストロフィー:世界の臨床試験レビュー(2021年上半期)
市場調査レポート
商品コード
1008204

デュシェンヌ型筋ジストロフィー:世界の臨床試験レビュー(2021年上半期)

Duchenne Muscular Dystrophy - Global Clinical Trials Review, H1, 2021

出版日: | 発行: GlobalData | ページ情報: 英文 204 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
デュシェンヌ型筋ジストロフィー:世界の臨床試験レビュー(2021年上半期)
出版日: 2021年05月20日
発行: GlobalData
ページ情報: 英文 204 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、デュシェンヌ型筋ジストロフィーについて調査しており、世界主要国において実施された臨床試験数とその平均登録数の概要、地域・フェーズ・臨床試験ステータス・エンドポイントステータス・スポンサータイプ別の臨床試験、臨床試験が進行中の薬剤、過去5年間の登録動向などのデータを掲載しています。

目次

目次

表のリスト

図のリスト

  • レポートガイダンス
  • 臨床試験調査範囲
  • 地域別の臨床試験
  • 国別の臨床試験と平均登録
  • アジア太平洋において臨床試験に貢献している主要5か国
  • 欧州において臨床試験に貢献している主要5か国
  • 北米において臨床試験に貢献している主要国
  • 中東とアフリカにおいて臨床試験に貢献している主要国
  • 中南米において臨床試験に貢献している主要5か国
  • G7諸国別:遺伝性疾患の臨床試験におけるデュシェンヌ型筋ジストロフィーの割合
  • フェーズ別:G7諸国における臨床試験
  • 臨床試験ステータス別:G7諸国における臨床試験
  • E7諸国別:遺伝性疾患の臨床試験におけるデュシェンヌ型筋ジストロフィーの割合
  • フェーズ別:E7諸国における臨床試験
  • 臨床試験ステータス別:E7諸国における臨床試験
  • フェーズ別の臨床試験
  • フェーズ別の進行中の臨床試験
  • 臨床試験ステータス別の臨床試験
  • エンドポイントステータス別の臨床試験
  • 一定期間にわたって募集された被験者
  • スポンサータイプ別の臨床試験
  • 主要スポンサー
  • 治療薬の臨床試験に参加している主要企業
  • 主要薬剤
  • 臨床試験プロファイルのスナップショット

付録

  • 略語
  • 定義
  • 調査手法
  • 2次調査
  • GlobalDataについて
  • お問い合わせ
  • 免責事項
  • 情報源
図表

List of Tables

List of Tables

  • Duchenne Muscular Dystrophy Therapeutics, Global, Clinical Trials by Region, 2021*
  • Duchenne Muscular Dystrophy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
  • Duchenne Muscular Dystrophy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Europe, Top Five Countries, 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, North America, Top Countries, 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2021*
  • Proportion of Duchenne Muscular Dystrophy to Genetic Disorders Clinical Trials, G7 Countries (%), 2021*
  • Duchenne Muscular Dystrophy Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
  • Duchenne Muscular Dystrophy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
  • Proportion of Duchenne Muscular Dystrophy to Genetic Disorders Clinical Trials, E7 Countries (%), 2021*
  • Duchenne Muscular Dystrophy Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
  • Duchenne Muscular Dystrophy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
  • Duchenne Muscular Dystrophy Therapeutics, Global, Clinical Trials by Phase, 2021*
  • Duchenne Muscular Dystrophy Therapeutics, Global, Clinical Trials In Progress by Phase 2021*
  • Duchenne Muscular Dystrophy Therapeutics, Global, Clinical Trials by Trial Status, 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, by End Point Status, 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2016-2020
  • Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*

List of Figures

List of Figures

  • Duchenne Muscular Dystrophy Therapeutics, Global, Clinical Trials by Region (%), 2021*
  • Duchenne Muscular Dystrophy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
  • Duchenne Muscular Dystrophy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, North America, Top Countries (%), 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2021*
  • Proportion of Duchenne Muscular Dystrophy to Genetic Disorders Clinical Trials, G7 Countries (%), 2021*
  • Duchenne Muscular Dystrophy Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
  • Duchenne Muscular Dystrophy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
  • Proportion of Duchenne Muscular Dystrophy to Genetic Disorders Clinical Trials, E7 Countries (%), 2021*
  • Duchenne Muscular Dystrophy Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
  • Duchenne Muscular Dystrophy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
  • Duchenne Muscular Dystrophy Therapeutics, Global, Clinical Trials by Phase (%), 2021*
  • Duchenne Muscular Dystrophy Therapeutics, Global, Clinical Trials In Progress by Phase, 2021*
  • Duchenne Muscular Dystrophy Therapeutics, Global, Clinical Trials by Trial Status, 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, by End Point Status, 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2016-2020
  • Duchenne Muscular Dystrophy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
  • Duchenne Muscular Dystrophy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*
  • GlobalData Methodology
目次
Product Code: GDHC6684CTIDB

GlobalData's clinical trial report, "Duchenne Muscular Dystrophy - Global Clinical Trials Review, H1, 2021" provides an overview of Duchenne Muscular Dystrophy Clinical trials scenario. This report provides top line data relating to the clinical trials on Duchenne Muscular Dystrophy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Duchenne Muscular Dystrophy to Genetic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Duchenne Muscular Dystrophy to Genetic Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Duchenne Muscular Dystrophy Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source